Pros | ![]() 3Y returns in the top 25% of the category. | ![]() 3Y returns in the top 25% of the category. ![]() Larger AUM within category. | ||
Cons | - | - |
INDMoney rank | - | - | ||
Category,Subcateogry | Equity,Index Funds | Equity,Index Funds | ||
Fund Age | 4 Years | 4 Years | ||
Fund Size | 166 Cr | 8199 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹100 | SIP ₹500 Lumpsum ₹1000 | ||
Expense Ratio | 0.51% | 0.43% | ||
Exit Load | 0% | 0% | ||
Benchmark Index | MSCI Ind Dom & Wld HealthC 45 NR INR | Nifty200 Momentum 30 TR INR |
No of Holdings | 48 | 31 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (11.45%) Max Healthcare Institute Ltd Ordinary Shares (6.77%) Cipla Ltd (6.14%) Divi's Laboratories Ltd (5.51%) Apollo Hospitals Enterprise Ltd (5.28%) | InterGlobe Aviation Ltd (5.42%) ICICI Bank Ltd (5.38%) HDFC Bank Ltd (5.27%) SBI Life Insurance Co Ltd (5.14%) Bharti Airtel Ltd (5.04%) | ||
No of Sectors | 1 | 8 | ||
Top 3 Sectors | Health (100%) | Financial Services (49.29%) Industrial (15.06%) Tech (9.37%) | ||
Equity % | 99.77% | 99.9% | ||
Debt % | - | - | ||
P/E | 32.98 | 39.06 | ||
P/B | 5.89 | 6.84 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -2.01% | -1.47% | ||
3-Month Return | 5.37% | -1.27% | ||
6-Month Return | 5.44% | 8.71% | ||
1-Year Return | 0.82% | -17.46% | ||
3-Year Return | 19.4% | 17.03% | ||
5-Year Return | - | - |
Sharpe | 0.95 | 0.74 | ||
Alpha | - | -0.17 | ||
Beta | - | 1 | ||
Standard Deviation | 12.39 | 18.23 | ||
Information Ratio | - | -1.12 |
Description | Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | UTI Nifty200 Momentum 30 Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Bhavesh Jain,Amit Vora | Ayush Jain,Sharwan Kumar Goyal |